Turquoise Health raised $40 million in a Series C round to expand beyond price transparency into managing healthcare ...

Stryker was hit by a cyberattack this week that knocked out its internal systems worldwide and caused delays to order ...

GLP-1s have proven to be highly effective for obesity, but are extremely expensive and often have serious side effects, such as nausea, vomiting, dizziness and fatigue. That’s why Noom, a digital ...

An NYU Stern report links private equity in healthcare to worse outcomes and higher bankruptcy risk, calling for reforms and stronger oversight.

When the 2025 Medicare Advantage Star Ratings were announced, only 42% of plans with prescription drug coverage scored four or five stars, down from 68% in 2022. This marks the third consecutive year ...

The high price of prescription drugs isn’t just hitting patients in the pocketbook. Non-adherence, often driven by high prices, costs the healthcare system between $100 billion and $290 billion every ...

Employer groups praised a bill aimed at boosting healthcare competition and lowering costs by banning anticompetitive insurer ...

Compounded versions of Novo Nordisk’s Wegovy and Ozempic will need to stop production soon. Lawsuits over these products are ongoing, but a federal court ruling in Texas means that compounding ...

Isaac Health, a virtual memory clinic, unveiled a new eight-week virtual group series on Wednesday to reduce the risk of dementia. The New York City-based startup works with healthcare organizations ...

Providence announced this week that it wants to sell its health plan, signaling its desire to exit the “payvider” club. Being a payvider — an organization that both provides healthcare services and ...

Sarepta Therapeutics’ report of a second fatality this year in a patient dosed with its Duchenne muscular dystrophy gene therapy raised the prospect it might have to pull the product from the market.